Project Grant R35GM158016

Award Date 6/1/25
Completion Date 4/30/30
Dollars Obligated $584K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Illinois, USA
Similar Awards
The University of Washington was awarded a $441,250 Project Grant from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) to conduct research investigating regulators of bacterial chromosome organization. The project aims to: 1) elucidate the mechanism of the GAPR protein as a model for understanding how bacteria and bacteriophages control positive supercoiling to proliferate; 2) identify additional topoisomerase...
The National Institute of General Medical Sciences (NIGMS) awarded a 5-year, $788,940 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to the University of Nebraska Medical Center (UNMC) to investigate the function of bacterial cytoskeletal elements in the division and growth of the FtsZ-less Chlamydia bacteria. The research aims to better understand how Chlamydia, an obligate intracellular bacterial pathogen that causes serious diseases in humans, divides and maintains...
This federal Project Grant award of $401,253 from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training Program (CFDA 93.859), supports research to elucidate novel cyclic nucleotide signaling pathways and physiological effects in bacteria. The research program aims to investigate the molecular mechanisms that control 2',3'-cyclic nucleotide monophosphate (2',3'-cNMP) signaling in bacteria, including its effects on transcription,...
The National Institute of General Medical Sciences (NIGMS) awarded New York University a $402,500 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to develop a novel approach that combines modular fluorophores and correlative super-resolution microscopy to investigate the structure, dynamics, and interactome of biomolecular condensates in bacteria. The project aims to apply this opto-proteomic toolbox to understand the role of these condensates in various...
This $462,500 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) aims to decipher the genetic regulation of bacterial heterogeneity in response to antibiotic stress using single-cell transcriptomics. The research, conducted at St. Jude Children's Research Hospital, will employ bacterial single-cell RNA sequencing technology to map the genetic factors driving bacterial heterogeneity and elucidate...
This $1,003,736 federal Project Grant award, funded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859), supports research to expand the understanding of post-transcriptional regulation of gene expression in bacteria. The research program has two main sub-projects: 1) Investigating epitranscriptomic regulation of gene expression across various bacterial species, and 2) Exploring the regulatory roles of novel...
The University of Massachusetts (UMass) was awarded a $438,629 project grant (R35GM156188) by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859). The purpose of this 5-year project is to investigate the fundamental mechano-molecular mechanisms governing the high-fidelity process of cell division. The research will utilize advanced live-cell imaging, molecular, and biochemical methods to characterize the...
The National Institute of General Medical Sciences (NIGMS) awarded a $750,730 Project Grant under the Biomedical Research and Research Training Program (CFDA 93.859) to the University of Illinois. The grant, effective August 16, 2024 through July 31, 2029, supports two research projects: Investigating the role of the smallest subunit of the Origin Recognition Complex (ORC), ORC6, in regulating DNA replication progression and mismatch repair. This project aims to answer fundamental questions...
This $383,746 federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research to characterize the molecular mechanisms and evolution of cyclic diguanylic acid (c-di-GMP) signaling in the antibiotic-producing bacterial genus Streptomyces. The research will focus on three key areas: (1) understanding how c-di-GMP regulates the developmental life cycle in the model species Streptomyces...
The federal Project Grant award R35GM157008, worth $350,487.00, was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859). The award aims to establish how divergent bacterial diheme proteins stabilize high-valent bis-FeIV states and use these intermediates to accomplish site-specific substrate oxidation. The research will address outstanding questions related to the formation, stabilization, and...

This federal Project Grant award in the amount of $583,698.00 was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The grant funds research conducted by the University of Illinois to investigate the molecular mechanisms that govern the coordination of the bacterial cell cycle, with a focus on understanding how bacteria coordinate chromosome replication, centromere segregation, and regulation of cell size/shape. The 5-year project aims to (1) define how the replication initiator protein DnaA and the partitioning system ParABS coordinate the initiation of chromosome replication with centromere segregation, and (2) uncover mechanisms that bacteria use to integrate environmental signals like nutrient availability into the cell cycle network. This research has the potential to transform the ability to control bacterial growth and drive biomedical innovations.

Generated 6/17/25, 2:31 AM